Mosight LP
Moxifloxacin 0.5% / Loteprednol 0.5% eye drops
The combination of Moxifloxacin + Loteprednol etabonate ophthalmic suspension is commonly prescribed to treat bacterial eye infections while simultaneously controlling ocular inflammation. It combines a broad-spectrum antibiotic with a corticosteroid.
Mechanism of action
-
Moxifloxacin 0.5%
-
A fourth-generation fluoroquinolone antibiotic.
-
Inhibits bacterial DNA gyrase and topoisomerase IV, leading to rapid bacterial death.
-
Effective against many Gram-positive and Gram-negative ocular pathogens.
-
-
Loteprednol etabonate (0.2%, 0.5%, or formulation-specific strength)
-
A "soft steroid" designed to reduce inflammation with a lower risk of raising intraocular pressure than many traditional corticosteroids.
-
Suppresses inflammatory mediators, reducing redness, pain, swelling, and photophobia.
-
